Named Patient Program (NPP) in Lebanon

How the named patient program (npp) pathway operates in Lebanon.

About Named Patient Program (NPP)

The foundational pathway for providing individual patients access to drugs not yet registered in their country.

How Named Patient Program (NPP) works in Lebanon

Lebanon's MoPH has a functional (if under-resourced) named-patient pathway for unregistered drugs.

Patients in Lebanon seeking access under Named Patient Program (NPP) typically follow this flow: a licensed physician in Lebanon issues the prescription and clinical justification, the regulator reviews and authorises, and an authorised operator coordinates import.

Documents required in Lebanon

  • Physician prescription and clinical-justification letter.
  • Patient identification and consent.
  • Country-specific NPP/personal-import form.
  • Hospital or clinic attestation where required.

Typical timeline

End-to-end 2-6 weeks in most tier 3 jurisdictions. Cellular and gene therapies may require additional ethics-committee review.

Start a request

Start a request under Named Patient Program (NPP) in Lebanon

AI disclosure & medical review. Content on this page is reviewed by Reserve Meds's AI clinical and regulatory review agents. A US-licensed human pharmacist (sourced through Altima Care, a US-licensed specialty wholesaler) reviews every prescription before dispensing. Regulatory posture is AI-summarized and not legal advice; case-specific questions route to retained outside counsel. Last medically reviewed: .
WhatsApp